GE HealthCare and Raydiant Oximetry announced a joint initiative to co-develop advanced fetal oxygen saturation monitoring technology. The collaboration centers on Raydiant’s Lumerah system, a non-invasive transabdominal pulse oximeter designed to better detect fetal distress during labor.
The FDA-designated breakthrough device recently completed an early feasibility study involving 30 women in labor. GE HealthCare will integrate this technology into its fetal monitoring and digital perinatal platforms to improve real-time decision-making during childbirth.
Leaders from both companies emphasized the potential to elevate standard care and outcomes for mothers and infants by enhancing how clinicians assess fetal well-being.
Follow MEDWIRE.AI for maternal health tech innovations.
